183 related articles for article (PubMed ID: 26747509)
1. "I Kicked the Hard Way. I Got Incarcerated." Withdrawal from Methadone During Incarceration and Subsequent Aversion to Medication Assisted Treatments.
Maradiaga JA; Nahvi S; Cunningham CO; Sanchez J; Fox AD
J Subst Abuse Treat; 2016 Mar; 62():49-54. PubMed ID: 26747509
[TBL] [Abstract][Full Text] [Related]
2. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
[TBL] [Abstract][Full Text] [Related]
3. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
4. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
[TBL] [Abstract][Full Text] [Related]
5. Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
Uebelacker LA; Bailey G; Herman D; Anderson B; Stein M
J Subst Abuse Treat; 2016 Jul; 66():48-53. PubMed ID: 27211996
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.
Moore KE; Oberleitner L; Smith KMZ; Maurer K; McKee SA
J Addict Med; 2018; 12(2):156-162. PubMed ID: 29341974
[TBL] [Abstract][Full Text] [Related]
7. Does incarceration influence patients' goals for opioid use disorder treatment? A qualitative study of buprenorphine treatment in jail.
Vail W; Faro E; Watnick D; Giftos J; Fox AD
Drug Alcohol Depend; 2021 May; 222():108529. PubMed ID: 33810909
[TBL] [Abstract][Full Text] [Related]
8. Our Ethical Obligation to Treat Opioid Use Disorder in Prisons: A Patient and Physician's Perspective.
Bone C; Eysenbach L; Bell K; Barry DT
J Law Med Ethics; 2018 Jun; 46(2):268-271. PubMed ID: 30146992
[TBL] [Abstract][Full Text] [Related]
9. Impact of jail-based methadone or buprenorphine treatment on non-fatal opioid overdose after incarceration.
Cherian T; Lim S; Katyal M; Goldfeld KS; McDonald R; Wiewel E; Khan M; Krawczyk N; Braunstein S; Murphy SM; Jalali A; Jeng PJ; Rosner Z; MacDonald R; Lee JD
Drug Alcohol Depend; 2024 Jun; 259():111274. PubMed ID: 38643529
[TBL] [Abstract][Full Text] [Related]
10. A randomized, open label trial of methadone continuation versus forced withdrawal in a combined US prison and jail: Findings at 12 months post-release.
Brinkley-Rubinstein L; McKenzie M; Macmadu A; Larney S; Zaller N; Dauria E; Rich J
Drug Alcohol Depend; 2018 Mar; 184():57-63. PubMed ID: 29402680
[TBL] [Abstract][Full Text] [Related]
11. Forced withdrawal from methadone maintenance therapy in criminal justice settings: a critical treatment barrier in the United States.
Fu JJ; Zaller ND; Yokell MA; Bazazi AR; Rich JD
J Subst Abuse Treat; 2013; 44(5):502-5. PubMed ID: 23433809
[TBL] [Abstract][Full Text] [Related]
12. Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
Binswanger IA
N Engl J Med; 2019 Mar; 380(13):1193-1195. PubMed ID: 30811904
[No Abstract] [Full Text] [Related]
13. "Just fighting for my life to stay alive": a qualitative investigation of barriers and facilitators to community re-entry among people with opioid use disorder and incarceration histories.
Hoffman KA; Thompson E; Gaeta Gazzola M; Oberleitner LMS; Eller A; Madden LM; Marcus R; Oberleitner DE; Beitel M; Barry DT
Addict Sci Clin Pract; 2023 Mar; 18(1):16. PubMed ID: 36944998
[TBL] [Abstract][Full Text] [Related]
14. Incarceration and opioid withdrawal: the experiences of methadone patients and out-of-treatment heroin users.
Mitchell SG; Kelly SM; Brown BS; Reisinger HS; Peterson JA; Ruhf A; Agar MH; Schwartz RP
J Psychoactive Drugs; 2009 Jun; 41(2):145-52. PubMed ID: 19705676
[TBL] [Abstract][Full Text] [Related]
15. Consumer attitudes about opioid addiction treatment: a focus group study in New York City.
Sohler NL; Weiss L; Egan JE; López CM; Favaro J; Cordero R; Cunningham CO
J Opioid Manag; 2013; 9(2):111-9. PubMed ID: 23709320
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with interest in receiving prison-based methadone maintenance therapy in Malaysia.
Mukherjee TI; Wickersham JA; Desai MM; Pillai V; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2016 Jul; 164():120-127. PubMed ID: 27207155
[TBL] [Abstract][Full Text] [Related]
17. Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Sufrin C; Sutherland L; Beal L; Terplan M; Latkin C; Clarke JG
Addiction; 2020 Nov; 115(11):2057-2065. PubMed ID: 32141128
[TBL] [Abstract][Full Text] [Related]
18. Impact of incarceration on rates of methadone use in a community recruited cohort of injection drug users.
Koehn JD; Bach P; Hayashi K; Nguyen P; Kerr T; Milloy MJ; Rieb L; Wood E
Addict Behav; 2015 Jul; 46():1-4. PubMed ID: 25746159
[TBL] [Abstract][Full Text] [Related]
19. Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
Trigg BG; Dickman SL
Subst Abus; 2012; 33(1):76-84. PubMed ID: 22263716
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine for managing opioid withdrawal.
Gowing L; Ali R; White JM; Mbewe D
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD002025. PubMed ID: 28220474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
